Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724885 | SCV000231390 | uncertain significance | not provided | 2015-06-01 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000179184 | SCV000597897 | likely benign | not specified | 2016-08-05 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001086099 | SCV000755408 | likely benign | Cohen syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314657 | SCV000848656 | likely benign | Inborn genetic diseases | 2017-01-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001086099 | SCV001460999 | likely benign | Cohen syndrome | 2020-09-16 | no assertion criteria provided | clinical testing |